315 related articles for article (PubMed ID: 30560399)
1. Improved Delivery of CRISPR/Cas9 System Using Magnetic Nanoparticles into Porcine Fibroblast.
Hryhorowicz M; Grześkowiak B; Mazurkiewicz N; Śledziński P; Lipiński D; Słomski R
Mol Biotechnol; 2019 Mar; 61(3):173-180. PubMed ID: 30560399
[TBL] [Abstract][Full Text] [Related]
2. Cationic Polymer-Mediated CRISPR/Cas9 Plasmid Delivery for Genome Editing.
Zhang Z; Wan T; Chen Y; Chen Y; Sun H; Cao T; Songyang Z; Tang G; Wu C; Ping Y; Xu FJ; Huang J
Macromol Rapid Commun; 2019 Mar; 40(5):e1800068. PubMed ID: 29708298
[TBL] [Abstract][Full Text] [Related]
3. Polyethylenimine based magnetic nanoparticles mediated non-viral CRISPR/Cas9 system for genome editing.
Rohiwal SS; Dvorakova N; Klima J; Vaskovicova M; Senigl F; Slouf M; Pavlova E; Stepanek P; Babuka D; Benes H; Ellederova Z; Stieger K
Sci Rep; 2020 Mar; 10(1):4619. PubMed ID: 32165679
[TBL] [Abstract][Full Text] [Related]
4. The combinational use of CRISPR/Cas9-based gene editing and targeted toxin technology enables efficient biallelic knockout of the α-1,3-galactosyltransferase gene in porcine embryonic fibroblasts.
Sato M; Miyoshi K; Nagao Y; Nishi Y; Ohtsuka M; Nakamura S; Sakurai T; Watanabe S
Xenotransplantation; 2014; 21(3):291-300. PubMed ID: 24919525
[TBL] [Abstract][Full Text] [Related]
5. Robust genome editing in adult vascular endothelium by nanoparticle delivery of CRISPR-Cas9 plasmid DNA.
Zhang X; Jin H; Huang X; Chaurasiya B; Dong D; Shanley TP; Zhao YY
Cell Rep; 2022 Jan; 38(1):110196. PubMed ID: 34986352
[TBL] [Abstract][Full Text] [Related]
6. Establishment of CRISPR/Cas9-Mediated Knock-in System for Porcine Cells with High Efficiency.
Zhang J; Zhu Z; Yue W; Li J; Chen Q; Yan Y; Lei A; Hua J
Appl Biochem Biotechnol; 2019 Sep; 189(1):26-36. PubMed ID: 30859452
[TBL] [Abstract][Full Text] [Related]
7. Manipulating the Biosynthesis of Bioactive Compound Alkaloids for Next-Generation Metabolic Engineering in Opium Poppy Using CRISPR-Cas 9 Genome Editing Technology.
Alagoz Y; Gurkok T; Zhang B; Unver T
Sci Rep; 2016 Aug; 6():30910. PubMed ID: 27483984
[TBL] [Abstract][Full Text] [Related]
8. Increasing the efficiency of CRISPR-Cas9-VQR precise genome editing in rice.
Hu X; Meng X; Liu Q; Li J; Wang K
Plant Biotechnol J; 2018 Jan; 16(1):292-297. PubMed ID: 28605576
[TBL] [Abstract][Full Text] [Related]
9. Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium glutamicum.
Liu J; Wang Y; Lu Y; Zheng P; Sun J; Ma Y
Microb Cell Fact; 2017 Nov; 16(1):205. PubMed ID: 29145843
[TBL] [Abstract][Full Text] [Related]
10. Fabrication and characterization of PLGA nanoparticles encapsulating large CRISPR-Cas9 plasmid.
Jo A; Ringel-Scaia VM; McDaniel DK; Thomas CA; Zhang R; Riffle JS; Allen IC; Davis RM
J Nanobiotechnology; 2020 Jan; 18(1):16. PubMed ID: 31959180
[TBL] [Abstract][Full Text] [Related]
11. Harnessing the native type I-B CRISPR-Cas for genome editing in a polyploid archaeon.
Cheng F; Gong L; Zhao D; Yang H; Zhou J; Li M; Xiang H
J Genet Genomics; 2017 Nov; 44(11):541-548. PubMed ID: 29169919
[TBL] [Abstract][Full Text] [Related]
12. Cas9, Cpf1 and C2c1/2/3-What's next?
Nakade S; Yamamoto T; Sakuma T
Bioengineered; 2017 May; 8(3):265-273. PubMed ID: 28140746
[TBL] [Abstract][Full Text] [Related]
13. Generation of porcine fetal fibroblasts expressing the tetracycline-inducible Cas9 gene by somatic cell nuclear transfer.
Liu G; Liu K; Wei H; Li L; Zhang S
Mol Med Rep; 2016 Sep; 14(3):2527-33. PubMed ID: 27430306
[TBL] [Abstract][Full Text] [Related]
14. Chromatin accessibility and guide sequence secondary structure affect CRISPR-Cas9 gene editing efficiency.
Jensen KT; Fløe L; Petersen TS; Huang J; Xu F; Bolund L; Luo Y; Lin L
FEBS Lett; 2017 Jul; 591(13):1892-1901. PubMed ID: 28580607
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in CRISPR/Cas9 mediated genome editing in Bacillus subtilis.
Hong KQ; Liu DY; Chen T; Wang ZW
World J Microbiol Biotechnol; 2018 Sep; 34(10):153. PubMed ID: 30269229
[TBL] [Abstract][Full Text] [Related]
16. AAV-Mediated CRISPR/Cas Gene Editing of Retinal Cells In Vivo.
Hung SS; Chrysostomou V; Li F; Lim JK; Wang JH; Powell JE; Tu L; Daniszewski M; Lo C; Wong RC; Crowston JG; Pébay A; King AE; Bui BV; Liu GS; Hewitt AW
Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3470-6. PubMed ID: 27367513
[TBL] [Abstract][Full Text] [Related]
17. Temperature effect on CRISPR-Cas9 mediated genome editing.
Xiang G; Zhang X; An C; Cheng C; Wang H
J Genet Genomics; 2017 Apr; 44(4):199-205. PubMed ID: 28412228
[TBL] [Abstract][Full Text] [Related]
18. Targeted Mutagenesis of Guinea Pig Cytomegalovirus Using CRISPR/Cas9-Mediated Gene Editing.
Bierle CJ; Anderholm KM; Wang JB; McVoy MA; Schleiss MR
J Virol; 2016 Aug; 90(15):6989-6998. PubMed ID: 27226370
[TBL] [Abstract][Full Text] [Related]
19. Gene editing of MPS I human fibroblasts by co-delivery of a CRISPR/Cas9 plasmid and a donor oligonucleotide using nanoemulsions as nonviral carriers.
Schuh RS; de Carvalho TG; Giugliani R; Matte U; Baldo G; Teixeira HF
Eur J Pharm Biopharm; 2018 Jan; 122():158-166. PubMed ID: 29122734
[TBL] [Abstract][Full Text] [Related]
20. Editing of the Bacillus subtilis Genome by the CRISPR-Cas9 System.
Altenbuchner J
Appl Environ Microbiol; 2016 Sep; 82(17):5421-7. PubMed ID: 27342565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
